Citation Tools
PDFRegular and Young Investigator Award Abstracts
Combination Immunotherapies
886 Combined allogeneic NK cell and Herzuma® is effective in HER2-low breast cancer preclinical model by enhancing antibody-dependent cellular cytotoxicity
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 886 Combined allogeneic NK cell and Herzuma® is effective in HER2-low breast cancer preclinical model by enhancing antibody-dependent cellular cytotoxicity